EC
TMCI icon

EntryPoint Capital’s Treace Medical Concepts TMCI Stock Holding History

EntryPoint Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,788
Closed -$144K – 960
2024
Q3 		$144K Sell
24,788
-9,840
-28% -$63.2K 0.08% 520
2024
Q2 		$230K Buy
+34,628
New +$280K 0.11% 329

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

EntryPoint Capital's TMCI Position: Q4 2024 in Review

EntryPoint Capital sold out of Treace Medical Concepts (TMCI) in Q4 2024, closing a stake of 24,788 shares — an estimated $144K sold.

EntryPoint Capital first reported a position in TMCI in Q2 2024 and held it in 2 quarters. The position peaked at $230K in Q2 2024. 135 funds tracked by Wall St. Rank hold TMCI as of Q4 2024.

  • EntryPoint Capital reported no remaining Treace Medical Concepts position as of Q4 2024 after selling out during the quarter.
  • EntryPoint Capital sold 24,788 Treace Medical Concepts shares in Q4 2024, an estimated $144K.
  • EntryPoint Capital first reported a position in Treace Medical Concepts in Q2 2024 and held it in 2 quarters.
  • EntryPoint Capital's Treace Medical Concepts position peaked at $230K in Q2 2024.
  • 135 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2024.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.